Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
about
Activation of p53, inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoids in immortalized human mammary epithelial cellsFenretinide and cancer prevention.Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer.Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?Race is a fundamental prognostic indicator for 2325 northeastern Ohio women with infiltrating breast cancer.Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.Synthetic retinoid fenretinide in breast cancer chemoprevention.Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative OncologyUpregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR).Novel non-isotopic method for the localization of receptors in tissue sections.Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women.Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
P2860
Q24803840-21E3CA3F-A1E4-411C-8135-936AED660DDDQ34107940-D3BF5BD4-973E-4FA3-82D6-66A039E7AB49Q34434006-E46CCBDA-8DCA-444E-AC7F-2FD0585307FFQ35830496-1BF80D5F-3D6F-4882-8E8C-06BA79041B0BQ36054089-65886DE1-8C65-4AB2-885A-2AAE6438F5A6Q36641887-DC6893F5-F1AA-4C31-AE17-B7E30834AE14Q36788454-E956D370-DDF7-44E9-A444-1ED93A544746Q37099659-98188486-15C6-423D-A135-C7583F562639Q38362494-261EE503-60F2-40D1-A974-1E1317824006Q43810208-D3CD7749-7E21-4CD5-AFF5-8F4AA4135824Q43835711-5DCB7F5B-6577-48BA-84F4-4DA83FA9BBA4Q44068904-E12A82AC-246B-43FF-A46B-F2BF1EE7F24E
P2860
Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Modulation of the insulin-like ...... uman breast cancer cell lines.
@ast
Modulation of the insulin-like ...... uman breast cancer cell lines.
@en
type
label
Modulation of the insulin-like ...... uman breast cancer cell lines.
@ast
Modulation of the insulin-like ...... uman breast cancer cell lines.
@en
prefLabel
Modulation of the insulin-like ...... uman breast cancer cell lines.
@ast
Modulation of the insulin-like ...... uman breast cancer cell lines.
@en
P2093
P2860
P356
P1476
Modulation of the insulin-like ...... human breast cancer cell lines
@en
P2093
A de Cupis
R E Favoni
P2860
P2888
P304
P356
10.1038/BJC.1998.358
P407
P50
P577
1998-06-01T00:00:00Z